Kalsheker N A, Hodgson I J, Watkins G L, White J P, Morrison H M, Stockley R A
Br Med J (Clin Res Ed). 1987 Jun 13;294(6586):1511-4. doi: 10.1136/bmj.294.6586.1511.
Specific gene probes were used to study restriction fragment length polymorphisms of the human alpha 1-antitrypsin gene. A polymorphism due to loss of a recognition site for the restriction enzyme Taq I was identified in eight of 42 patients with bronchiectasis and nine of 49 patients with pulmonary emphysema, none of whom had alpha 1-antitrypsin deficiency. Among a control group without lung disease the polymorphism was significantly less frequent, being found in only five of 101 apparently healthy blood donors. The deoxyribonucleic acid (DNA) polymorphism was also present in two of 14 unrelated patients with alpha 1-antitrypsin deficiency, indicating a lack of association with any specific alpha 1-antitrypsin protein phenotype. The polymorphism identified in this study may be a new marker for genetic predisposition to chronic lung disease.
使用特异性基因探针研究人类α1 -抗胰蛋白酶基因的限制性片段长度多态性。在42例支气管扩张患者中有8例以及49例肺气肿患者中有9例发现了一种由于限制性内切酶Taq I识别位点缺失导致的多态性,这些患者均无α1 -抗胰蛋白酶缺乏症。在无肺部疾病的对照组中,这种多态性的出现频率显著较低,在101名表面健康的献血者中仅5例发现。在14例无亲缘关系的α1 -抗胰蛋白酶缺乏症患者中也有2例存在这种脱氧核糖核酸(DNA)多态性,这表明它与任何特定的α1 -抗胰蛋白酶蛋白表型均无关联。本研究中鉴定出的这种多态性可能是慢性肺部疾病遗传易感性的一种新标记。